Literature DB >> 7643825

Munchausen's syndrome and other factitious disorders.

D G Folks1.   

Abstract

Factitious disorders including Munchausen's syndrome are likely encountered by all clinicians during their career. Neurologic presentations are common, especially with Munchausen's syndrome by proxy. An appropriate index of suspicion and nonjudgemental confrontation and psychiatric consultation facilitate a successful clinical approach. Redefining the factitious illness as psychiatric with continued involvement of a primary physician and family support are also keys to successful management. Underlying psychiatric syndromes need to be assiduously evaluated and steadfastly treated. Prognosis is best for patients who do not meet criteria for Munchausen's syndrome or who have psychosocial supports and less severe personality pathology.

Entities:  

Mesh:

Year:  1995        PMID: 7643825

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  5 in total

1.  'Virtual' factitious disorders and Munchausen by proxy.

Authors:  M D Feldman; M Bibby; S D Crites
Journal:  West J Med       Date:  1998-06

Review 2.  Factitious disorder (Munchausen's syndrome) in oncology: case report and literature review.

Authors:  Muhammad R Baig; Tomer T Levin; Wendy G Lichtenthal; Patrick J Boland; William S Breitbart
Journal:  Psychooncology       Date:  2015-07-14       Impact factor: 3.894

3.  Munchausen's Syndrome.

Authors:  Sevin Altınkaynak; Vildan Ertekin; Handan Alp; Tülin Fidan
Journal:  Eurasian J Med       Date:  2009-08

4.  Early death in Munchausen syndrome: A case report.

Authors:  Rosaria Di Lorenzo; Ludovica Lannocca; Maritea Burattini; Andrea Vasta; Martina Galletti; Alessandro Minarini; Francesca Mongelli; Salvatore Sportiello; Sergio Rovesti; Paola Ferri
Journal:  Clin Case Rep       Date:  2019-06-20

5.  Factitious disorder in saudi arabia: a report of two cases.

Authors:  T A Al-Habeeb
Journal:  J Family Community Med       Date:  1999-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.